Typical timeline
6–18 months
Broadly mirrors CE Marking timelines; UK Approved Body capacity is a current constraint.
United Kingdom
UKCA Marking
The UK's post-Brexit conformity mark for the Great Britain market, overseen by the MHRA.
Overview
What UKCA is and why it matters
UKCA (UK Conformity Assessed) marking is required to place most medical devices on the Great Britain market. The UK government has adjusted the CE-to-UKCA transition timeline more than once since Brexit — manufacturers should confirm the current transition deadline directly with the MHRA before assuming CE Marking alone remains sufficient for GB.
Requirements
What you'll need
The documentation and evidence a complete submission is normally built from.
- Device classification aligned to UK MDR 2002 (as amended)
- UK Approved Body conformity assessment (Class IIa and above)
- UK Responsible Person appointed (non-UK manufacturers)
- Technical documentation
- MHRA device registration
- Confirm current CE-recognition transition deadline with MHRA before relying on CE Marking alone for GB
Planning ranges
Typical timeline and estimated cost
Ranges illustrate general market patterns for this pathway — they are not a quote for a specific product.
Estimated cost
$15k–$120k
Comparable to CE Marking costs for an equivalent device class.
Timelines and costs above are typical ranges illustrating general market patterns, not a quote or regulatory conclusion for your specific product. Actual figures depend on device classification, target country, and applicant readiness — professional review is required before relying on this for a business decision.
Where this applies
Applicable countries
Jurisdictions that recognise this certification. Scope and conditions still vary by product classification.
United Kingdom (Great Britain)
Related
Regulatory Pathways
FAQ
Frequently asked questions
Is CE Marking still accepted in Great Britain?
The UK has extended recognition of CE Marking for GB more than once since Brexit — the current deadline should always be confirmed directly with the MHRA rather than assumed from past guidance.
Does UKCA apply in Northern Ireland?
Northern Ireland follows a different arrangement under the Windsor Framework — this page covers Great Britain (England, Scotland, Wales) only.
Related
Related Certifications
Reviewed packages
Buy a defined outcome
Pay for a market-access outcome — not a feature tour
Market Entry Sprint from $2,500 · Strategy Session $500 · Pathway Brief $1,800. Professional review required before business use. No patient data on public forms.
Reviewed launch planning
Need a UKCA pathway brief?
UKCA pathway briefs start at $1,800. Or book a $2,500 Market Entry Sprint that includes regulatory pathway outline, evidence flags, and a review call.
Professional review is required before business use.